Landscape Capital Management, L.L.C. Novo Cure LTD Transaction History

Landscape Capital Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$12.42 - $17.29 $128,323 - $178,640	10,332 New	10,332 $161,000
Q3 2022 Nov 02, 2022	BUY	$67.99 - $89.57 $1.83 Million - $2.41 Million	26,891 New	26,891 $2.04 Million
Q4 2021 Feb 01, 2022	SELL	$75.08 - $121.99 $1.79 Million - $2.91 Million	-23,885 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$116.17 - $194.55 $1.07 Million - $1.8 Million	9,246 Added 63.16%	23,885 $2.78 Million
Q2 2021 Aug 03, 2021	SELL	$130.4 - $225.58 $1.28 Million - $2.21 Million	-9,801 Reduced 40.1%	14,639 $3.25 Million
Q1 2021 May 11, 2021	BUY	$124.11 - $190.17 $2.15 Million - $3.29 Million	17,306 Added 242.58%	24,440 $3.23 Million
Q4 2020 Feb 09, 2021	BUY	$112.16 - $174.14 $87,260 - $135,480	778 Added 12.24%	7,134 $1.23 Million
Q3 2020 Nov 10, 2020	BUY	$58.05 - $111.31 $368,965 - $707,486	6,356 New	6,356 $707,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.